img

Global Probiotic Pills Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Probiotic Pills Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Probiotic Pills market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Probiotic Pills is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Probiotic Pills is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Probiotic Pills is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Probiotic Pills include L.P Gentle Herbal, OHKISEIYAKU, Nutrition Care Pharmaceuticals, Eishin Pharmaceutical Co., Ltd., Votary, Smidge, CVS Caremark and DSM, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Probiotic Pills, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Probiotic Pills by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Probiotic Pills market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Probiotic Pills market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


L.P Gentle Herbal
OHKISEIYAKU
Nutrition Care Pharmaceuticals
Eishin Pharmaceutical Co., Ltd.
Votary
Smidge
CVS Caremark
DSM
By Type
Capsule
Medicinal Tablet
Other
By Application
Drugstore
Clinic
E-commerce
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Probiotic Pills in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Probiotic Pills manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Probiotic Pills sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Probiotic Pills Definition
1.2 Market by Type
1.2.1 Global Probiotic Pills Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Capsule
1.2.3 Medicinal Tablet
1.2.4 Other
1.3 Market Segment by Application
1.3.1 Global Probiotic Pills Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Drugstore
1.3.3 Clinic
1.3.4 E-commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Probiotic Pills Sales
2.1 Global Probiotic Pills Revenue Estimates and Forecasts 2018-2034
2.2 Global Probiotic Pills Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Probiotic Pills Revenue by Region
2.3.1 Global Probiotic Pills Revenue by Region (2018-2024)
2.3.2 Global Probiotic Pills Revenue by Region (2024-2034)
2.4 Global Probiotic Pills Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Probiotic Pills Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Probiotic Pills Sales Quantity by Region
2.6.1 Global Probiotic Pills Sales Quantity by Region (2018-2024)
2.6.2 Global Probiotic Pills Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Probiotic Pills Sales Quantity by Manufacturers
3.1.1 Global Probiotic Pills Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Probiotic Pills Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Probiotic Pills Sales in 2022
3.2 Global Probiotic Pills Revenue by Manufacturers
3.2.1 Global Probiotic Pills Revenue by Manufacturers (2018-2024)
3.2.2 Global Probiotic Pills Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Probiotic Pills Revenue in 2022
3.3 Global Probiotic Pills Sales Price by Manufacturers
3.4 Global Key Players of Probiotic Pills, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Probiotic Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Probiotic Pills, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Probiotic Pills, Product Offered and Application
3.8 Global Key Manufacturers of Probiotic Pills, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Probiotic Pills Sales Quantity by Type
4.1.1 Global Probiotic Pills Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Probiotic Pills Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Probiotic Pills Sales Quantity Market Share by Type (2018-2034)
4.2 Global Probiotic Pills Revenue by Type
4.2.1 Global Probiotic Pills Historical Revenue by Type (2018-2024)
4.2.2 Global Probiotic Pills Forecasted Revenue by Type (2024-2034)
4.2.3 Global Probiotic Pills Revenue Market Share by Type (2018-2034)
4.3 Global Probiotic Pills Price by Type
4.3.1 Global Probiotic Pills Price by Type (2018-2024)
4.3.2 Global Probiotic Pills Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Probiotic Pills Sales Quantity by Application
5.1.1 Global Probiotic Pills Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Probiotic Pills Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Probiotic Pills Sales Quantity Market Share by Application (2018-2034)
5.2 Global Probiotic Pills Revenue by Application
5.2.1 Global Probiotic Pills Historical Revenue by Application (2018-2024)
5.2.2 Global Probiotic Pills Forecasted Revenue by Application (2024-2034)
5.2.3 Global Probiotic Pills Revenue Market Share by Application (2018-2034)
5.3 Global Probiotic Pills Price by Application
5.3.1 Global Probiotic Pills Price by Application (2018-2024)
5.3.2 Global Probiotic Pills Price Forecast by Application (2024-2034)
6 North America
6.1 North America Probiotic Pills Sales by Company
6.1.1 North America Probiotic Pills Revenue by Company (2018-2024)
6.1.2 North America Probiotic Pills Sales Quantity by Company (2018-2024)
6.2 North America Probiotic Pills Market Size by Type
6.2.1 North America Probiotic Pills Sales Quantity by Type (2018-2034)
6.2.2 North America Probiotic Pills Revenue by Type (2018-2034)
6.3 North America Probiotic Pills Market Size by Application
6.3.1 North America Probiotic Pills Sales Quantity by Application (2018-2034)
6.3.2 North America Probiotic Pills Revenue by Application (2018-2034)
6.4 North America Probiotic Pills Market Size by Country
6.4.1 North America Probiotic Pills Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Probiotic Pills Revenue by Country (2018-2034)
6.4.3 North America Probiotic Pills Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Probiotic Pills Sales by Company
7.1.1 Europe Probiotic Pills Sales Quantity by Company (2018-2024)
7.1.2 Europe Probiotic Pills Revenue by Company (2018-2024)
7.2 Europe Probiotic Pills Market Size by Type
7.2.1 Europe Probiotic Pills Sales Quantity by Type (2018-2034)
7.2.2 Europe Probiotic Pills Revenue by Type (2018-2034)
7.3 Europe Probiotic Pills Market Size by Application
7.3.1 Europe Probiotic Pills Sales Quantity by Application (2018-2034)
7.3.2 Europe Probiotic Pills Revenue by Application (2018-2034)
7.4 Europe Probiotic Pills Market Size by Country
7.4.1 Europe Probiotic Pills Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Probiotic Pills Revenue by Country (2018-2034)
7.4.3 Europe Probiotic Pills Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Probiotic Pills Sales by Company
8.1.1 China Probiotic Pills Sales Quantity by Company (2018-2024)
8.1.2 China Probiotic Pills Revenue by Company (2018-2024)
8.2 China Probiotic Pills Market Size by Type
8.2.1 China Probiotic Pills Sales Quantity by Type (2018-2034)
8.2.2 China Probiotic Pills Revenue by Type (2018-2034)
8.3 China Probiotic Pills Market Size by Application
8.3.1 China Probiotic Pills Sales Quantity by Application (2018-2034)
8.3.2 China Probiotic Pills Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Probiotic Pills Sales by Company
9.1.1 APAC Probiotic Pills Sales Quantity by Company (2018-2024)
9.1.2 APAC Probiotic Pills Revenue by Company (2018-2024)
9.2 APAC Probiotic Pills Market Size by Type
9.2.1 APAC Probiotic Pills Sales Quantity by Type (2018-2034)
9.2.2 APAC Probiotic Pills Revenue by Type (2018-2034)
9.3 APAC Probiotic Pills Market Size by Application
9.3.1 APAC Probiotic Pills Sales Quantity by Application (2018-2034)
9.3.2 APAC Probiotic Pills Revenue by Application (2018-2034)
9.4 APAC Probiotic Pills Market Size by Region
9.4.1 APAC Probiotic Pills Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Probiotic Pills Revenue by Region (2018-2034)
9.4.3 APAC Probiotic Pills Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Probiotic Pills Sales by Company
10.1.1 Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Probiotic Pills Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Probiotic Pills Market Size by Type
10.2.1 Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Probiotic Pills Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Probiotic Pills Market Size by Application
10.3.1 Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Probiotic Pills Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Probiotic Pills Market Size by Country
10.4.1 Middle East, Africa and Latin America Probiotic Pills Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Probiotic Pills Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 L.P Gentle Herbal
11.1.1 L.P Gentle Herbal Company Information
11.1.2 L.P Gentle Herbal Overview
11.1.3 L.P Gentle Herbal Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 L.P Gentle Herbal Probiotic Pills Products and Services
11.1.5 L.P Gentle Herbal Probiotic Pills SWOT Analysis
11.1.6 L.P Gentle Herbal Recent Developments
11.2 OHKISEIYAKU
11.2.1 OHKISEIYAKU Company Information
11.2.2 OHKISEIYAKU Overview
11.2.3 OHKISEIYAKU Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 OHKISEIYAKU Probiotic Pills Products and Services
11.2.5 OHKISEIYAKU Probiotic Pills SWOT Analysis
11.2.6 OHKISEIYAKU Recent Developments
11.3 Nutrition Care Pharmaceuticals
11.3.1 Nutrition Care Pharmaceuticals Company Information
11.3.2 Nutrition Care Pharmaceuticals Overview
11.3.3 Nutrition Care Pharmaceuticals Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Nutrition Care Pharmaceuticals Probiotic Pills Products and Services
11.3.5 Nutrition Care Pharmaceuticals Probiotic Pills SWOT Analysis
11.3.6 Nutrition Care Pharmaceuticals Recent Developments
11.4 Eishin Pharmaceutical Co., Ltd.
11.4.1 Eishin Pharmaceutical Co., Ltd. Company Information
11.4.2 Eishin Pharmaceutical Co., Ltd. Overview
11.4.3 Eishin Pharmaceutical Co., Ltd. Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Eishin Pharmaceutical Co., Ltd. Probiotic Pills Products and Services
11.4.5 Eishin Pharmaceutical Co., Ltd. Probiotic Pills SWOT Analysis
11.4.6 Eishin Pharmaceutical Co., Ltd. Recent Developments
11.5 Votary
11.5.1 Votary Company Information
11.5.2 Votary Overview
11.5.3 Votary Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Votary Probiotic Pills Products and Services
11.5.5 Votary Probiotic Pills SWOT Analysis
11.5.6 Votary Recent Developments
11.6 Smidge
11.6.1 Smidge Company Information
11.6.2 Smidge Overview
11.6.3 Smidge Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Smidge Probiotic Pills Products and Services
11.6.5 Smidge Probiotic Pills SWOT Analysis
11.6.6 Smidge Recent Developments
11.7 CVS Caremark
11.7.1 CVS Caremark Company Information
11.7.2 CVS Caremark Overview
11.7.3 CVS Caremark Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 CVS Caremark Probiotic Pills Products and Services
11.7.5 CVS Caremark Probiotic Pills SWOT Analysis
11.7.6 CVS Caremark Recent Developments
11.8 DSM
11.8.1 DSM Company Information
11.8.2 DSM Overview
11.8.3 DSM Probiotic Pills Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 DSM Probiotic Pills Products and Services
11.8.5 DSM Probiotic Pills SWOT Analysis
11.8.6 DSM Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Probiotic Pills Value Chain Analysis
12.2 Probiotic Pills Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Probiotic Pills Production Mode & Process
12.4 Probiotic Pills Sales and Marketing
12.4.1 Probiotic Pills Sales Channels
12.4.2 Probiotic Pills Distributors
12.5 Probiotic Pills Customers
13 Market Dynamics
13.1 Probiotic Pills Industry Trends
13.2 Probiotic Pills Market Drivers
13.3 Probiotic Pills Market Challenges
13.4 Probiotic Pills Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Probiotic Pills Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Medicinal Tablet
Table 4. Major Manufacturers of Other
Table 5. Global Probiotic Pills Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Probiotic Pills Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Probiotic Pills Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Probiotic Pills Revenue Market Share by Region (2018-2024)
Table 9. Global Probiotic Pills Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Probiotic Pills Revenue Market Share by Region (2024-2034)
Table 11. Global Probiotic Pills Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global Probiotic Pills Sales by Region (2018-2024) & (K Units)
Table 13. Global Probiotic Pills Sales Market Share by Region (2018-2024)
Table 14. Global Probiotic Pills Sales by Region (2024-2034) & (K Units)
Table 15. Global Probiotic Pills Sales Market Share by Region (2024-2034)
Table 16. Global Probiotic Pills Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global Probiotic Pills Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Probiotic Pills Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Probiotic Pills Revenue Share by Manufacturers (2018-2024)
Table 20. Global Probiotic Pills Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Key Players of Probiotic Pills, Industry Ranking, 2021 VS 2022
Table 22. Global Probiotic Pills Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Probiotic Pills by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Probiotic Pills as of 2022)
Table 24. Global Key Manufacturers of Probiotic Pills, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Probiotic Pills, Product Offered and Application
Table 26. Global Key Manufacturers of Probiotic Pills, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Probiotic Pills Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global Probiotic Pills Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Probiotic Pills Sales Quantity Share by Type (2018-2024)
Table 31. Global Probiotic Pills Sales Quantity Share by Type (2024-2034)
Table 32. Global Probiotic Pills Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Probiotic Pills Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Probiotic Pills Revenue Share by Type (2018-2024)
Table 35. Global Probiotic Pills Revenue Share by Type (2024-2034)
Table 36. Probiotic Pills Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Probiotic Pills Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Probiotic Pills Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global Probiotic Pills Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Probiotic Pills Sales Quantity Share by Application (2018-2024)
Table 41. Global Probiotic Pills Sales Quantity Share by Application (2024-2034)
Table 42. Global Probiotic Pills Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Probiotic Pills Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Probiotic Pills Revenue Share by Application (2018-2024)
Table 45. Global Probiotic Pills Revenue Share by Application (2024-2034)
Table 46. Probiotic Pills Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Probiotic Pills Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. North America Probiotic Pills Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Probiotic Pills Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America Probiotic Pills Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America Probiotic Pills Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Probiotic Pills Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Probiotic Pills Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Probiotic Pills Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America Probiotic Pills Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Probiotic Pills Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Probiotic Pills Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Probiotic Pills Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Probiotic Pills Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Probiotic Pills Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Probiotic Pills Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America Probiotic Pills Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Probiotic Pills Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe Probiotic Pills Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Probiotic Pills Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe Probiotic Pills Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Probiotic Pills Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Probiotic Pills Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Probiotic Pills Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe Probiotic Pills Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Probiotic Pills Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Probiotic Pills Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Probiotic Pills Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Probiotic Pills Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Probiotic Pills Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Probiotic Pills Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe Probiotic Pills Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Probiotic Pills Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China Probiotic Pills Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Probiotic Pills Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China Probiotic Pills Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Probiotic Pills Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Probiotic Pills Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Probiotic Pills Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China Probiotic Pills Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Probiotic Pills Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Probiotic Pills Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Probiotic Pills Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC Probiotic Pills Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Probiotic Pills Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC Probiotic Pills Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Probiotic Pills Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Probiotic Pills Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Probiotic Pills Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC Probiotic Pills Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Probiotic Pills Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Probiotic Pills Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Probiotic Pills Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Probiotic Pills Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Probiotic Pills Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Probiotic Pills Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC Probiotic Pills Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Probiotic Pills Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Probiotic Pills Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Probiotic Pills Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Probiotic Pills Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Probiotic Pills Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Probiotic Pills Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Probiotic Pills Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Probiotic Pills Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Probiotic Pills Sales Quantity by Country (2024-2034) & (K Units)
Table 118. L.P Gentle Herbal Company Information
Table 119. L.P Gentle Herbal Description and Overview
Table 120. L.P Gentle Herbal Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 121. L.P Gentle Herbal Probiotic Pills Product and Services
Table 122. L.P Gentle Herbal Probiotic Pills SWOT Analysis
Table 123. L.P Gentle Herbal Recent Developments
Table 124. OHKISEIYAKU Company Information
Table 125. OHKISEIYAKU Description and Overview
Table 126. OHKISEIYAKU Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 127. OHKISEIYAKU Probiotic Pills Product and Services
Table 128. OHKISEIYAKU Probiotic Pills SWOT Analysis
Table 129. OHKISEIYAKU Recent Developments
Table 130. Nutrition Care Pharmaceuticals Company Information
Table 131. Nutrition Care Pharmaceuticals Description and Overview
Table 132. Nutrition Care Pharmaceuticals Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 133. Nutrition Care Pharmaceuticals Probiotic Pills Product and Services
Table 134. Nutrition Care Pharmaceuticals Probiotic Pills SWOT Analysis
Table 135. Nutrition Care Pharmaceuticals Recent Developments
Table 136. Eishin Pharmaceutical Co., Ltd. Company Information
Table 137. Eishin Pharmaceutical Co., Ltd. Description and Overview
Table 138. Eishin Pharmaceutical Co., Ltd. Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 139. Eishin Pharmaceutical Co., Ltd. Probiotic Pills Product and Services
Table 140. Eishin Pharmaceutical Co., Ltd. Probiotic Pills SWOT Analysis
Table 141. Eishin Pharmaceutical Co., Ltd. Recent Developments
Table 142. Votary Company Information
Table 143. Votary Description and Overview
Table 144. Votary Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 145. Votary Probiotic Pills Product and Services
Table 146. Votary Probiotic Pills SWOT Analysis
Table 147. Votary Recent Developments
Table 148. Smidge Company Information
Table 149. Smidge Description and Overview
Table 150. Smidge Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 151. Smidge Probiotic Pills Product and Services
Table 152. Smidge Probiotic Pills SWOT Analysis
Table 153. Smidge Recent Developments
Table 154. CVS Caremark Company Information
Table 155. CVS Caremark Description and Overview
Table 156. CVS Caremark Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 157. CVS Caremark Probiotic Pills Product and Services
Table 158. CVS Caremark Probiotic Pills SWOT Analysis
Table 159. CVS Caremark Recent Developments
Table 160. DSM Company Information
Table 161. DSM Description and Overview
Table 162. DSM Probiotic Pills Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 163. DSM Probiotic Pills Product and Services
Table 164. DSM Probiotic Pills SWOT Analysis
Table 165. DSM Recent Developments
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Probiotic Pills Distributors List
Table 169. Probiotic Pills Customers List
Table 170. Probiotic Pills Market Trends
Table 171. Probiotic Pills Market Drivers
Table 172. Probiotic Pills Market Challenges
Table 173. Probiotic Pills Market Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Probiotic Pills Product Picture
Figure 2. Global Probiotic Pills Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Probiotic Pills Market Share by Type in 2022 & 2034
Figure 4. Capsule Product Picture
Figure 5. Medicinal Tablet Product Picture
Figure 6. Other Product Picture
Figure 7. Global Probiotic Pills Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Probiotic Pills Market Share by Application in 2022 & 2034
Figure 9. Drugstore
Figure 10. Clinic
Figure 11. E-commerce
Figure 12. Probiotic Pills Report Years Considered
Figure 13. Global Probiotic Pills Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Probiotic Pills Revenue 2018-2034 (US$ Million)
Figure 15. Global Probiotic Pills Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Probiotic Pills Sales Quantity 2018-2034 (K Units)
Figure 17. Global Probiotic Pills Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Probiotic Pills Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Probiotic Pills Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Probiotic Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Probiotic Pills Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Probiotic Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Probiotic Pills Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Probiotic Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Probiotic Pills Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Probiotic Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Probiotic Pills Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Probiotic Pills Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Probiotic Pills Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Probiotic Pills Revenue in 2022
Figure 31. Probiotic Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Probiotic Pills Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Probiotic Pills Revenue Market Share by Type (2018-2034)
Figure 34. Global Probiotic Pills Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Probiotic Pills Revenue Market Share by Application (2018-2034)
Figure 36. North America Probiotic Pills Revenue Market Share by Company in 2022
Figure 37. North America Probiotic Pills Sales Quantity Market Share by Company in 2022
Figure 38. North America Probiotic Pills Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Probiotic Pills Revenue Market Share by Type (2018-2034)
Figure 40. North America Probiotic Pills Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Probiotic Pills Revenue Market Share by Application (2018-2034)
Figure 42. North America Probiotic Pills Revenue Share by Country (2018-2034)
Figure 43. North America Probiotic Pills Sales Quantity Share by Country (2018-2034)
Figure 44. United States Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Probiotic Pills Sales Quantity Market Share by Company in 2022
Figure 47. Europe Probiotic Pills Revenue Market Share by Company in 2022
Figure 48. Europe Probiotic Pills Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Probiotic Pills Revenue Market Share by Type (2018-2034)
Figure 50. Europe Probiotic Pills Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Probiotic Pills Revenue Market Share by Application (2018-2034)
Figure 52. Europe Probiotic Pills Revenue Share by Country (2018-2034)
Figure 53. Europe Probiotic Pills Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 55. France Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 59. China Probiotic Pills Sales Quantity Market Share by Company in 2022
Figure 60. China Probiotic Pills Revenue Market Share by Company in 2022
Figure 61. China Probiotic Pills Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Probiotic Pills Revenue Market Share by Type (2018-2034)
Figure 63. China Probiotic Pills Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Probiotic Pills Revenue Market Share by Application (2018-2034)
Figure 65. APAC Probiotic Pills Sales Quantity Market Share by Company in 2022
Figure 66. APAC Probiotic Pills Revenue Market Share by Company in 2022
Figure 67. APAC Probiotic Pills Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Probiotic Pills Revenue Market Share by Type (2018-2034)
Figure 69. APAC Probiotic Pills Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Probiotic Pills Revenue Market Share by Application (2018-2034)
Figure 71. APAC Probiotic Pills Revenue Share by Region (2018-2034)
Figure 72. APAC Probiotic Pills Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 77. India Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Probiotic Pills Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Probiotic Pills Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Probiotic Pills Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Probiotic Pills Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Probiotic Pills Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Probiotic Pills Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Probiotic Pills Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Probiotic Pills Revenue Share by Country (2018-2034)
Figure 86. Brazil Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Probiotic Pills Revenue (2018-2034) & (US$ Million)
Figure 91. Probiotic Pills Value Chain
Figure 92. Probiotic Pills Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed